Omid Farokhzad, MD

Associate Professor at Harvard Medical School (HMS)
Co-Founder of Bind Biosciences, Selecta Biosciences

Omid Farokhzad, MD, is an Associate Professor at Harvard Medical School (HMS) and a physician-scientist in the Department of Anesthesiology at Brigham and Women’s Hospital (BWH). Dr. Farokhzad directs the Laboratory of Nanomedicine and Biomaterials at BWH. He is a faculty member of the Brigham Research Institute Cancer Research Center at BWH. He is additionally a member of the Dana Farber/Harvard Cancer Center Programs in Prostate Cancer and Cancer Cell Biology. He is a Research Affiliate in the Harvard-MIT Division of Health Sciences and Technology (HST). Dr. Farokhzad has extensive experience with the development of therapeutic nanoparticle technologies; most notably, he pioneered the high throughput development and screening of multifunctional nanoparticles for medical applications. Dr. Farokhzad has authored more than 70 papers and is an inventor of more than 60 issued/pending patents. The combinatorial nanoparticle self-assembly technologies that Dr. Farokhzad has developed formed the foundation for the launch of two venture-backed biotechnology companies, BIND Biosciences and Selecta Biosciences. These companies are translating the aforementioned academic innovations towards clinical development. He serves as Director on the board of BIND and as Director and Vice Chairman on the board of Selecta. Dr. Farokhzad was named among the Nano50 winners of 2007 by Nanotech Briefs, which awards the most innovative people and design ideas that will revolutionize nanotechnology. In 2009 he was among the 15 recipients across all industries to receive the All Star Distinguished Achievement Award from the Mass High Tech (MHT) Journal for his contributions to the Life Sciences industry. Dr. Farokhzad completed his post-doctoral clinical and research trainings, respectively, at the BWH/HMS and MIT in the laboratory of Dr. Robert Langer. He received his M.D. and M.A. from Boston University School of Medicine.